Metraipolis › archive › dc_c79976e1c44e

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41590508

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41590508
DOI
10.3390/jpm16010015
License (as archived)
solo-consultazione
Archived
2026-11-07T03:14:22.652Z
SHA-256 of the archived text
a2be66ea56edaa1162446c3842ad479266b6817ef3291256997d44582c832472
Stable URL of this page
https://metraipolis.com/documento/dc_c79976e1c44e

How to cite

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41590508 — Europe PMC (en), https://europepmc.org/article/MED/41590508 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c79976e1c44e (Metraipolis archive dc_c79976e1c44e, sha256 a2be66ea56edaa1162446c3842ad479266b6817ef3291256997d44582c832472)
BibTeX
@misc{dcc79976e1c44e,
  title = {The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1 — Europe PMC PMID:41590508},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41590508},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c79976e1c44e; sha256 a2be66ea56edaa1162446c3842ad479266b6817ef3291256997d44582c832472},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41590508. Agents can read the archived copy with the MCP tool read_document.